1,3-Benzodioxole-Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin-Bound Structure.

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Cancer Biology

Background:

• Noscapine, a weak anti-mitotic agent, has spurred research for more potent derivatives.
• Previous studies explored modifications at various noscapine positions, leaving the 1,3-benzodioxole motif largely uninvestigated.

Purpose of the Study:

• To design, synthesize, and evaluate novel noscapine analogues with modifications to the 1,3-benzodioxole moiety.
• To enhance anti-proliferative potency and overcome drug resistance mechanisms.

Main Methods:

• Synthesis of noscapine analogues featuring expanded dioxolane rings and deuterium/fluorine incorporation.
• Pharmacological evaluation using cancer cell lines (MCF-7, NCI screen) and tubulin polymerization assays.
• X-ray crystallography to determine the binding structure of a novel derivative with tubulin.

Main Results:

• Deuterated derivative 14e and dioxino analogue 20 demonstrated potent cytotoxicity (EC50 values 1.50 μM and 0.73 μM, respectively) against MCF-7 breast cancer cells.
• Compound 20 showed broad-spectrum activity (EC50 < 2 μM) against melanoma, lung, brain, kidney, and breast cancer cell lines.
• Both compounds inhibit tubulin polymerization and are effective against P-gp overexpressing drug-resistant breast cancer cells.

Conclusions:

• Modifications to the 1,3-benzodioxole moiety represent a promising strategy for developing potent noscapine-based anti-cancer agents.
• Novel analogues 14e and 20 exhibit significant anti-proliferative activity and overcome drug resistance.
• Structural insights from X-ray crystallography will guide future optimization of noscapinoids for enhanced therapeutic properties.